Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.046 AUD | -4.17% | -11.54% | -25.81% |
Mar. 25 | Transcript : Prescient Therapeutics Limited - Special Call | |
Feb. 23 | Prescient Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-11-27 | |
Melanie Leydin
DFI | Director of Finance/CFO | 51 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Engle
CHM | Chairman | 69 | 14-11-27 |
James Campbell
BRD | Director/Board Member | - | 14-11-27 |
Ellen Feigal
BRD | Director/Board Member | 69 | 23-05-14 |
Chief Executive Officer | - | 14-11-27 | |
Allen Ebens
BRD | Director/Board Member | - | 20-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 805,319,793 | 688,506,507 ( 85.49 %) | 0 | 85.49 % |
Company contact information
Prescient Therapeutics Ltd.
100 Albert Road Level 4
3205, South Melbourne
+
http://www.ptxtherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
-25.81% | 24.5M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+28.07% | 12.14B | |
+0.17% | 12.15B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- PTX Stock
- Company Prescient Therapeutics Limited